Is glutathione supplementation harmful to the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glutathione Supplementation and Liver Health

Glutathione supplementation is not harmful to the liver and may actually be beneficial in certain liver conditions, though evidence for routine supplementation in healthy individuals is limited.

Glutathione and Liver Function

Glutathione (GSH) is the most important low-molecular-weight antioxidant synthesized in cells, serving as a crucial reducing molecule that neutralizes reactive oxygen species 1. The liver is the primary site of glutathione synthesis, and this antioxidant plays several important roles in liver health:

  • Acts as a major cellular antioxidant
  • Participates in detoxification processes
  • Helps maintain redox balance in hepatocytes
  • Protects against oxidative stress-induced liver damage

Evidence for Safety and Potential Benefits

In Liver Disease

  • In patients with chronic steatosic liver disease (both alcohol and non-alcohol related), glutathione administration has been shown to significantly improve liver function tests including bilirubin, GOT, GPT, and GT, with benefits persisting even after treatment discontinuation 2
  • High-dose intravenous glutathione (1800 mg/day) has demonstrated optimal results in patients with fatty liver disease 2
  • Glutathione deficiency is considered a pathophysiological hallmark in both alcoholic and non-alcoholic liver diseases 1

In Specific Patient Populations

  • In burn patients, additional enteral doses of glutamine (0.3-0.5 g/kg/day) are recommended for 10-15 days, as glutamine is a precursor to glutathione 3
  • Similarly, in critically ill trauma patients, additional enteral glutamine (0.2-0.3 g/kg/day) can be administered for the first five days 3
  • For other ICU patients, enteral glutamine is not recommended 3

Limitations and Considerations

Despite the theoretical benefits, some studies show mixed results:

  • A randomized controlled trial in cirrhotic patients found that glutathione supplementation (500 mg/day for 12 weeks) did not significantly affect indicators of oxidative stress or antioxidant capacities 4
  • However, baseline glutathione levels were associated with disease severity, suggesting its importance in liver health 4

Monitoring Considerations

For patients taking glutathione supplements, particularly those with existing liver conditions:

  • Monitor GGT levels, as GGT is elevated in approximately 75% of habitual drinkers and can indicate liver stress 5
  • For mild isolated GGT elevation (<2× ULN) without identified cause, lifestyle modifications and repeat testing in 3 months are recommended 5
  • For moderate elevation (2-5× ULN), more frequent monitoring every 4-8 weeks is advised 5

Clinical Implications

The available evidence suggests that:

  1. Glutathione supplementation is not harmful to the liver
  2. It may be beneficial in specific liver conditions characterized by oxidative stress
  3. In patients with cirrhosis, glutathione levels in the epithelial lining fluid are significantly reduced, suggesting potential benefit from supplementation 6
  4. Serum glutathione reductase activity is elevated in various liver conditions, indicating the body's attempt to maintain glutathione homeostasis 7

Conclusion

Based on current evidence, glutathione supplementation appears safe for the liver and may offer benefits in certain liver conditions characterized by oxidative stress and glutathione depletion. However, routine supplementation in healthy individuals lacks strong supporting evidence, and supplementation should be considered primarily in specific clinical contexts where glutathione deficiency is likely.

References

Research

Glutathione in the treatment of liver diseases: insights from clinical practice.

Minerva gastroenterologica e dietologica, 2016

Research

[Glutathione in the treatment of chronic fatty liver diseases].

Recenti progressi in medicina, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Elevated GGT Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effects of chronic hepatic dysfunction on pulmonary glutathione homeostasis.

Alcoholism, clinical and experimental research, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.